ANALISIS MULTI DRUG RESISTANT PADA PASIEN TUBERKULOSIS DI INSTALASI RAWAT INAP RSUD Dr. MOEWARDI SURAKARTA TAHUN 2013 dan 2014

RASUBALA, Prisilia Jeqkline (2015) ANALISIS MULTI DRUG RESISTANT PADA PASIEN TUBERKULOSIS DI INSTALASI RAWAT INAP RSUD Dr. MOEWARDI SURAKARTA TAHUN 2013 dan 2014. Skripsi thesis, Universitas Setia Budi Surakarta.

	Text 01. INTISARI.pdf Download (175kB)
	Text 02. HALAMAN JUDUL - BAB I.pdf Restricted to Repository staff only Download (1MB) | Request a copy
	Text 03. BAB II.pdf Restricted to Repository staff only Download (305kB) | Request a copy
	Text 04. BAB III.pdf Restricted to Repository staff only Download (111kB) | Request a copy
	Text 05. BAB IV.pdf Restricted to Repository staff only Download (518kB) | Request a copy
	Text 06. BAB V - LAMPIRAN.pdf Restricted to Repository staff only Download (2MB) | Request a copy

Abstract

Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacillus. Management which substandard will result in treatment failure, continuous transmission of tuberculosis germs to family members and other community members as well as cause drug resistance or known case of Multi Drug Resistant – Tuberculosis (MDR-TB). This study was aimed to analyze the MDR-TB incidence among TB patients in Inpatient Department Dr. Moewardi Hospital Surakarta in 2013 and 2014. This research was descriptive study with data collection retrospectively in MDR-TB patient at Inpatient Department Dr. Moewardi Hospital Surakarta in 2013 and 2014. Data taken were age, gender, type of financing, lenght of stay, home state of patient and cormobidity. Antituberculosis drug usage in MDR-TB patient adjusted its usage by hospital formulary and guideline Kemenkes. The results indicate that antituberculosis drug which cause MDR-TB were combination of rifampicin + isoniazid; combination of rifampicin + isoniazid + ethambutol; combination of rifampicin + isoniazid + streptomycin and combination of rifampicin + isoniazid + ethambutol + streptomycin. Percentage of MDR-TB incidence in tuberculosis patient in 2013 as 43.24%, whereas in 2014 as 57.48%. MDR-TB incidence was greatest in 2014 with percentage 57.48%. conformity of antituberculosis drug usage with Formulary and Guideline Kemenkes was 100%. Kata Kunci: Multi Drug Resistant, tuberculosis

Item Type:	Thesis (Skripsi)
Uncontrolled Keywords:	Multi Drug Resistant, tuberculosis
Subjects:	R Medicine > R Medicine (General)
Divisions:	Fakultas Farmasi > Prodi S1 Farmasi
Depositing User:	Tifany Nur Arfiana
Date Deposited:	03 Oct 2019 03:49
Last Modified:	03 Oct 2019 03:49
URI:	http://repo.setiabudi.ac.id/id/eprint/1585

Actions (login required)

View Item